Results 1 to 10 of about 2,318,494 (246)
Immune Checkpoint Inhibitors in Cancer Therapy
The discovery of immune checkpoint proteins such as PD-1/PDL-1 and CTLA-4 represents a significant breakthrough in the field of cancer immunotherapy. Therefore, humanized monoclonal antibodies, targeting these immune checkpoint proteins have been utilized successfully in patients with metastatic melanoma, renal cell carcinoma, head and neck cancers and
Yavar Shiravand +8 more
openaire +6 more sources
Negative Immune Checkpoint Inhibitors
Checkpoint inhibitors are a modern therapeutic approach for treating various types of cancer, metabolic diseases, and chronic infections. The main goal of this therapy is to specifically unlock the immune system, allowing it to recognize and eliminate cancer cells or pathogens, primarily through the activation of T lymphocytes.
Magda Drewniak-Świtalska +2 more
openaire +4 more sources
SnapShot: Immune Checkpoint Inhibitors
Immunotherapy has changed the landscape of cancer treatment. Checkpoint blockade therapies unleash breaks in the immune system and induce long-lasting responses. However, a significant number of patients do not respond (innate resistance), and a subset progress after responding (acquired resistance).
Abril-Rodriguez, Gabriel, Ribas, Antoni
openaire +4 more sources
Cardiotoxicity of immune checkpoint inhibitors
Cardiac toxicity after conventional antineoplastic drugs (eg, anthracyclines) has historically been a relevant issue. In addition, targeted therapies and biological molecules can also induce cardiotoxicity. Immune checkpoint inhibitors are a novel class of anticancer drugs, distinct from targeted or tumour type-specific therapies.
VARRICCHI, GILDA +7 more
openaire +3 more sources
Immune Checkpoint Inhibitor–Induced Lipodystrophy
This case series describes lipodystrophy, a rare adverse event associated with immune checkpoint inhibitor therapy.
Riganti J. +15 more
openaire +3 more sources
Immune Checkpoint Inhibitors in Penile Cancer
Carlo Buonerba +9 more
openaire +3 more sources
Immune checkpoint inhibitor-related endocrinopathies
Lu, Difei, Gao, Ying
openaire +2 more sources
Immune Checkpoint Inhibitor-Induced Pancreatitis. [PDF]
Moro CF +9 more
europepmc +1 more source
Immune checkpoint inhibitor-associated cardiotoxicity: incidence, diagnosis, and management. [PDF]
Haddad SF +11 more
europepmc +1 more source
Immune Checkpoint Inhibitor-Associated Hemophagocytic Lymphohistiocytosis: A Systematic Review. [PDF]
Al-Mashdali AF +5 more
europepmc +1 more source

